Sarah Hale, MD
Advanced Heart Failure and Transplant Cardiology · Winfield, ILNPI 1053843219
Payments from drug & device makers
What this record shows
This record is dominated by grants: $10,500 of the $11,038 with a category attached, or 95.1%. Abbott accounts for 96.9% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2023 at $10,736 and has fallen 98.8% since, to $129 in 2025. That places this record below the midpoint for advanced heart failure and transplant cardiology clinicians in IL, where the typical reported total is $11,038.
Across 14 payments — averaging $788.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$11K
- Alnylam Pharmaceuticals Inc.$91
- Pfizer$54
- E.r. Squibb & Sons, L.L.C.$54
- Abiomed$41
- AstraZeneca$32
- plus $71 from 3 others
What the payments were for
- Grants$10,50095%
- Food & beverage$5385%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 4 | $10,694 |
| Alnylam Pharmaceuticals Inc. | 1 | $91 |
| Pfizer | 1 | $54 |
| E.r. Squibb & Sons, L.L.C. | 2 | $54 |
| Abiomed | 1 | $41 |
| AstraZeneca | 1 | $32 |
| Angiodynamics, Inc. | 2 | $28 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $22 |
| Scpharmaceuticals Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,038 in reported general payments places this provider in the 50th percentile of 56 advanced heart failure and transplant cardiology providers in Illinois.
See all advanced heart failure and transplant cardiology providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 34 | $31,630 |
| EntrestoSacubitril/Valsartan | 25 | $23,069 |
| Metoprolol Succinate | 23 | $284 |
| Spironolactone | 26 | $135 |
| Furosemide | 13 | $29 |
Paid to pharmacies, not to this prescriber.
Other advanced heart failure and transplant cardiology in Winfield
- Michele MontpetitWinfield$2K
- Maria Rosa CostanzoNaperville$716K
- Jonathan RichChicago$327K
- Esther VorovichChicago$224K
- Jane WilcoxChicago$220K
- Ali ValikaElmhurst$218K
- Manreet KanwarChicago$162K
- Jonathan GrinsteinChicago$128K
- Muhyaldee DiaOak Lawn$125K
- Bow ChungChicago$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.